Triple negative breast cancer is one of the most aggressive forms of the disease and accounts for about 20 percent of all breast cancers. It’s called triple negative because it does not have any of the main drivers of breast cancerthe estrogen receptor, the progesterone receptor, and the HER2 receptorand consequently doesn’t respond to treatments that target them. The main treatment is chemotherapy, immunotherapy or participation in clinical trials.
Is My Cancer Really Triple-Negative?
Dr. Heather McArthur, Clinical Director of the Breast Cancer Program at Simmons Cancer Center at UT Southwestern Medical Center, has spoken with SurvivorNet on this relevant topic.
Read MoreTherefore, it is exceedingly important to discuss with your physician about your HER2 status.
Learn more about SurvivorNet's rigorous medical review process.
